← SynDRA
Lck inhibitor
SynDRA canonical compound SYN0059071 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | LCK |
|---|
| Mechanism of action | SRC inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- RefChem:1088384
- TC-S-7003
- PyriMido[5',4'
- C31H30N8O
- orb1707088
- SCHEMBL5235694
- GLXC-04384
- BDBM50374608
- EX-A14658
- MFCD18782603
- AKOS024457690
- CS-1448
- NCGC00378811-02
- NCGC00378811-03
- DA-78276
- HY-12072
- MS-29811
- F84949
- T15726
- 6-(2,6-dimethylphenyl)-2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-one
Look up Lck inhibitor in the interactive SynDRA portal →